AHF Survey Of Gays Raises Questions About Gilead's Truvada For HIV Prevention
AHF's survey, which was presented yesterday as part of an HIV PrEP Symposium at UCLA, raises questions about the use of Truvada as an HIV prevention pill-or pre-exposure prophylaxis (PrEP). The online focus group was designed to determine "real world" reactions from prospective consumers about taking PrEP and to gain further information about potential adherence issues and the pill's possible impact on condom use.
No comments:
Post a Comment